Latest Articles

Publication Date
Endometriosis Therapeutics: A Market in Need, but Can Organon Still Lead? - AInvest

Endometriosis Therapeutics: A Market in Need, but Can Organon Still Lead? AInvest

Published: July 2, 2025, 1:04 p.m.
Organon halts development of endometriosis pain drug after trial failure By Investing.com - Investing.com Nigeria

Organon halts development of endometriosis pain drug after trial failure By Investing.com Investing.com Nigeria

Published: July 2, 2025, 12:52 p.m.
Organon Provides Update on Phase 2 ELENA Proof-Of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain - MarketScreener

Organon Provides Update on Phase 2 ELENA Proof-Of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain MarketScreener

Published: July 2, 2025, 12:51 p.m.
Organon Ends Development of OG-6219 After Endometriosis Trial Fails to Meet Primary Endpoint - MarketScreener

Organon Ends Development of OG-6219 After Endometriosis Trial Fails to Meet Primary Endpoint MarketScreener

Published: July 2, 2025, 12:10 p.m.
Organon halts development of endometriosis pain drug after trial failure By Investing.com - Investing.com Canada

Organon halts development of endometriosis pain drug after trial failure By Investing.com Investing.com Canada

Published: July 2, 2025, 12:08 p.m.
Organon to halt development of endometriosis pain drug after mid-stage trial failure - MarketScreener

Organon to halt development of endometriosis pain drug after mid-stage trial failure MarketScreener

Published: July 2, 2025, 11:52 a.m.
Organon abandons endometriosis pain drug development after trial failure - MarketScreener

Organon abandons endometriosis pain drug development after trial failure MarketScreener

Published: July 2, 2025, 11:52 a.m.
Organon halts development of endometriosis pain drug after trial failure - Investing.com

Organon halts development of endometriosis pain drug after trial failure Investing.com

Published: July 2, 2025, 11:42 a.m.
Endometriosis linked to four-times higher pregnancy rates than other causes of infertility, study reveals - Medical Xpress

Endometriosis linked to four-times higher pregnancy rates than other causes of infertility, study reveals Medical Xpress

Published: July 2, 2025, 11:33 a.m.
Organon's Promising Endometriosis Drug OG-6219 Falls Short in Critical Phase 2 Trial, Program Discontinued - Stock Titan

Organon's Promising Endometriosis Drug OG-6219 Falls Short in Critical Phase 2 Trial, Program Discontinued Stock Titan

Published: July 2, 2025, 11:30 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!